Breaking News, Financial News

Financial Report: Patheon 2Q10

Commercial manufacturing revenues were up 5% in the quarter to $142.2 million.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Patheon 2Q10

2Q Revenues: $175.4 million (+5%)

2Q Earnings: $10.9 million (loss of $3.2 million in 2Q09)

YTD Revenues: $330.2 million (+5%)

YTD Loss:
$0.2 million (loss of $12.6 million YTD09)

Comments: Commercial manufacturing revenues were up 5% in the quarter to$142.2 million. North American commercial revenues were up $1.3 million or (+2%). European commercial revenues increased by $5.7 million or 8%. Pharmaceutical Development Services (PDS) revenues increased 3% to $33.2 million. YTD revenues from commercial manufacturing increased 7% to $270.3 million. PDS revenues were down 3% to $59.9 million. Results in the quarter were aided by favorable currency exchange rates.

Click here to learn more about Patheon

Click here to view the Contracting & Outsourcing 2010 conference agenda!

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters